Cytokinetics, Incorporated ( CYTK) | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Cytokinetics, Incorporated ( CYTK)

An SI Board Since April 2004

Posts	SubjectMarks	Bans	Symbol
405	30	0	CYTK

Emcee: mopgcw	Type: Unmoderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
80	Oral CHF cpd selected. <i>Cytokinetics Announces Selection of CK-1827452	keokalani'nui	-	12/7/2005
79	Company is shooting for ACC 3/06 for results of P1 iv myosin program in healthie	keokalani'nui	-	11/29/2005
78	[Ispinesib in Phase I combo trials; AACR/EORTC data] >>SOUTH SAN FRANCISC	tuck	-	11/17/2005
77	Cytokinetics Announces Clinical and Non-Clinical Data on Ispinesib to Be Present	mopgcw	-	11/11/2005
76	sabry sold a few shares yesterday, joining trautman et al. BOO HISS.	mopgcw	-	11/10/2005
75	Cytokinetics, Incorporated Reports Third Quarter 2005 Financial Results Wednesda	mopgcw	-	10/29/2005
74	Cytokinetics Secures $75 Million Committed Equity Financing Facility Friday Octo	mopgcw	-	10/29/2005
73	Perhaps a bit of an over reaction as they are continuing one part -- platinum-se	mopgcw	-	9/29/2005
72	gs report; CYTK (IL/N): Early results on 992, GSK still key but CYTK steps up on	mopgcw	-	9/29/2005
71	[CK-1827452 preclinical data presented at AHFSA meeting] This adds a little col	tuck	-	9/27/2005
70	[Ispinesib goes to PII, but not in platinum-refractory NSCLC patients] >>	tuck	-	9/27/2005
69	CYTK given expanded role in GSK alliance for KSP inhibitors: >>SOUTH SAN	tuck	-	9/27/2005
68	Cytokinetics to Present Non-Clinical Data On CK-1827452 At the 2005 Annual Heart	mopgcw	-	9/12/2005
67	Cytokinetics Announces the Initiation of a Phase I Clinical Trial of CK-1827452	mopgcw	-	9/12/2005
66	gs: CYTK (IL/N): Q2 update, pipeline progressing 52-Week Range US$14-5 YTD Pri	mopgcw	-	7/29/2005
65	The cardiac myosin poster is now on the website: cytokinetics.com The x296 cpd	keokalani'nui	-	7/27/2005
64	Cytokinetics, Incorporated Reports Second Quarter 2005 Financial Results Wednesd	mopgcw	-	7/27/2005
63	Cytokinetics Presents Data from Heart Failure Program Wednesday July 27, 9:08 am	mopgcw	-	7/27/2005
62	Highlights from Goldman Sachs 26th Healthcare conference - ABGX, CYTK, GTXI, HGS	mopgcw	-	6/24/2005
61	Maybe, just maybe....co hoping shelf will be filled after some good news? nsclc	keokalani'nui	-	6/14/2005
60	perfect timing, stock trading well on its lows...idiots.	mopgcw	-	6/14/2005
59	Cytokinetics Files Shelf Registration Statement Tuesday June 14, 8:29 am ET SO	nigel bates	-	6/14/2005
58	Curr Top Med Chem. 2005;5(2):127-45. Related Articles, Links Mitotic kinesins	keokalani'nui	-	5/25/2005
57	More in the MPM: <i> Jim Scopa joined MPM Capital as a general partner	mopgcw	-	5/23/2005
56	No mention of responses, nor of dosing, just vague AE data for SB-743921. Typic	tuck	-	5/14/2005

Go to reply# or date (mm/dd/yy):